6869.T
6869.T
JP3351100007
SYSMEX CORP
Loading chart...

Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing; and antimicrobial susceptibility testing. The company also provides Caresphere, an ICT solution, which integrates and analyzes real time various data managed through testing instruments and clinical testing information systems, and supports the efficient operation of clinical laboratories; and involved in the medical robotics business. It serves products and services to medical institutions, clinical laboratories, animal hospitals, and research institutes. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Related stocks

7733.T
7733.T • Japan
OLYMPUS CORPORATION
2,000 JPY
13.43B USD 1Y +6.5%
6960.T
6960.T • Japan
FUKUDA DENSHI CO
11,220 JPY
1.92B USD 1Y +55.6%
4543.T
4543.T • Japan
TERUMO CORP
2,284 JPY
21.29B USD 1Y -8.9%
6523.T
6523.T • Japan
PHC HLDGS CORP
1,586 JPY
1.27B USD 1Y +63.8%
COH.AX
COH.AX • Australia
COCHLEAR FPO [COH]
128.39 AUD
5.87B USD 1Y -54.5%
7799.TW
7799.TW • Taiwan
HERON NEUTRON MEDICAL CORP.
518 TWD
2.57B USD 1Y -14.7%
6849.T
6849.T • Japan
NIHON KOHDEN CORP
1,643 JPY
1.66B USD 1Y -11.6%
688114.SS
688114.SS • China
MGI TECH CO LTD
67.95 CNY
4.23B USD 1Y -4.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.4% p.a.
Max Drawdown (5Y)
-75.4%
Sharpe Ratio (5Y)
-0.50
Beta Factor
0.77
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.4% in the extended horizon.
ende